IMMUNOPLUS
LIVE

Serial Number

79384162

Owner

Nanjing Genscript Biotech Co., Ltd

Filing Date

Sep 13, 2023

Add to watchlist:

No watchlists yet
View on USPTO

IMMUNOPLUS Trademark

Serial Number: 79384162 • Registration: 7410943

IMMUNOPLUS is a trademark filed by Nanjing Genscript Biotech Co., Ltd on September 13, 2023. The trademark is classified under Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Nanjing Genscript Biotech Co., Ltd (36 trademarks)

No.28 Yongxi Road, Jiangning Science Park,

Entity Type: 99

Trademark Details

Filing Date

September 13, 2023

Registration Date

June 11, 2024

Published for Opposition

March 26, 2024

Goods & Services

Scientific, technological and medical research services, namely, the service of providing gene synthesis, oligo synthesis, cloning, protein expression, peptide synthesis and antibody production, genome modification, cell line establishment, animal model establishment, in vivo and in vitro assays; product quality testing; biochemical research and analysis; gene therapy research; dna screening for scientific research purposes; biological cloning services; biological research and analysis; medical and scientific research, namely, conducting clinical trials for others; medical research; scientific research in the field of genetics; biological research; development of gene-based medicines; research and development services in the field of antibodies

Filing History

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
May 17, 2025 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Apr 29, 2025 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Apr 29, 2025 OPNR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jul 11, 2024 FICR
REGISTERED-PRINCIPAL REGISTER
Jun 11, 2024 R.PR
PUBLISHED FOR OPPOSITION
Mar 26, 2024 PUBO
NOTICE OF PUBLICATION
Mar 6, 2024 NPUB
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 20, 2024 CNSA
ASSIGNED TO EXAMINER
Feb 16, 2024 DOCK
APPLICATION FILING RECEIPT MAILED
Dec 22, 2023 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 18, 2023 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Dec 13, 2023 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Nov 30, 2023 REPR